In 2013 and 2015, we published studies demonstrating that high-dose oral or injected rapamycin significantly delays disease onset and extends survival in the Ndufs4(KO) mouse model of LS [109–111]. The gene discussed is NDUFS4; the disease is Leigh syndrome.